Different Taxanes, Similar Outcomes in Advanced HER2-Positive Breast Cancer
Final results from a routine-practice comparison of taxane agents showed that the drugs offered comparable safety and efficacy in advanced HER2-positive breast cancer. Median progression-free survival (PFS) was about 21 months and median overall survival (OS) was 65 months with dual anti-HER2 therapy and was similar among patients who received paclitaxel or docetaxel, as well […]
How confined protons migrate
The results described by the team of the Bochum Excellence Cluster Ruhr Explores Solvation, RESOLV for short, together with colleagues of the sister research network CALSOLV in Berkeley were published in the journal Angewandte Chemie on September 3rd, 2021. The reviewers rated the results as a Highlight Paper (Top 10%). Protons (H+) and hydronium ions […]
Trials reveal efficacy and safety of oral drug for treating anemia associated with kidney disease
Pooled results from recent clinical trials indicate that an oral drug called roxadustat is an effective treatment for anemia in patients with chronic kidney disease. The results are published in an upcoming issue of CJASN. Many individuals with kidney dysfunction develop anemia, or a shortage of healthy red blood cells that carry oxygen to the […]
Common weight-loss drug successfully targets fat that can endanger heart health
Researchers at UT Southwestern announced successful results of a clinical trial for a commonly prescribed weight-loss drug called liraglutide. In adults who are overweight or have obesity combined with high cardiovascular risk, once-daily liraglutide combined with lifestyle interventions significantly lowered two types of fat that have been associated with risk to heart health: visceral fat […]
What Is the Normal Range for Hepatitis B Surface Antibody?
Learn about how the hepatitis B surface antibody test works, and how its results indicate immunity to the virus Hepatitis B surface antibodies (anti-HBs or HBsAb) are measured in blood samples in milli-International Units/milliliter mIU/mL). The ranges for hepatitis B surface antibodies are: Anti-HBs greater than 10-12 mIU/mL: Protected against hepatitis B virus (HBV) infection, […]